However, a putative CRM1 binding site was identified near the C-terminus of the AR, and the rapid nuclear export of AR that occurs upon inhibition of GSK-3β in prostate cancer cells is blocked by Leptomycin B29,30. Here, GSK3B is linked to prostate cancer.